vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and FONAR CORP (FONR). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $18.9M, roughly 1.4× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs 8.0%, a 6.6% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs 2.4%). Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $-227.0K). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -0.3%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
ELMD vs FONR — Head-to-Head
Income Statement — Q2 2026 vs Q2 2026
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $25.5M |
| Net Profit | $2.8M | $2.1M |
| Gross Margin | 78.4% | — |
| Operating Margin | 19.2% | 13.5% |
| Net Margin | 14.6% | 8.0% |
| Revenue YoY | 16.3% | 2.4% |
| Net Profit YoY | 40.3% | 4.7% |
| EPS (diluted) | $0.32 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $25.5M | ||
| Q3 25 | $16.9M | $26.0M | ||
| Q2 25 | $17.4M | $27.3M | ||
| Q1 25 | $15.7M | $27.2M | ||
| Q4 24 | $16.3M | $24.9M | ||
| Q3 24 | $14.7M | $25.0M | ||
| Q2 24 | $14.8M | $25.9M | ||
| Q1 24 | $13.9M | $25.7M |
| Q4 25 | $2.8M | $2.1M | ||
| Q3 25 | $2.1M | $2.3M | ||
| Q2 25 | $2.2M | $729.3K | ||
| Q1 25 | $1.9M | $2.5M | ||
| Q4 24 | $2.0M | $2.0M | ||
| Q3 24 | $1.5M | $3.1M | ||
| Q2 24 | $1.8M | $830.4K | ||
| Q1 24 | $1.5M | $1.9M |
| Q4 25 | 78.4% | — | ||
| Q3 25 | 78.1% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 77.7% | — | ||
| Q3 24 | 78.3% | — | ||
| Q2 24 | 76.2% | — | ||
| Q1 24 | 74.8% | — |
| Q4 25 | 19.2% | 13.5% | ||
| Q3 25 | 15.8% | 14.1% | ||
| Q2 25 | 17.5% | 5.3% | ||
| Q1 25 | 13.6% | 15.2% | ||
| Q4 24 | 15.6% | 11.9% | ||
| Q3 24 | 13.2% | 21.0% | ||
| Q2 24 | 15.7% | 7.4% | ||
| Q1 24 | 13.3% | 16.8% |
| Q4 25 | 14.6% | 8.0% | ||
| Q3 25 | 12.6% | 8.7% | ||
| Q2 25 | 12.7% | 2.7% | ||
| Q1 25 | 12.1% | 9.2% | ||
| Q4 24 | 12.1% | 7.9% | ||
| Q3 24 | 10.0% | 12.6% | ||
| Q2 24 | 12.3% | 3.2% | ||
| Q1 24 | 10.8% | 7.3% |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $0.25 | — | ||
| Q2 25 | $0.26 | — | ||
| Q1 25 | $0.21 | — | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.16 | — | ||
| Q2 24 | $0.20 | — | ||
| Q1 24 | $0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | $121.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $176.9M |
| Total Assets | $54.9M | $217.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | $121.0K | ||
| Q3 25 | $14.1M | $122.0K | ||
| Q2 25 | $15.3M | $56.5M | ||
| Q1 25 | $15.2M | $123.0K | ||
| Q4 24 | $16.2M | $121.0K | ||
| Q3 24 | $13.9M | $136.0K | ||
| Q2 24 | $16.1M | $56.5M | ||
| Q1 24 | $11.7M | $134.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
| Q4 25 | $45.4M | $176.9M | ||
| Q3 25 | $44.7M | $174.9M | ||
| Q2 25 | $43.2M | $172.6M | ||
| Q1 25 | $43.9M | $171.9M | ||
| Q4 24 | $43.6M | $169.8M | ||
| Q3 24 | $41.5M | $168.7M | ||
| Q2 24 | $44.5M | $166.0M | ||
| Q1 24 | $42.5M | $165.8M |
| Q4 25 | $54.9M | $217.2M | ||
| Q3 25 | $53.6M | $218.4M | ||
| Q2 25 | $53.8M | $216.9M | ||
| Q1 25 | $52.5M | $214.9M | ||
| Q4 24 | $52.3M | $208.0M | ||
| Q3 24 | $48.9M | $212.3M | ||
| Q2 24 | $52.2M | $214.2M | ||
| Q1 24 | $48.9M | $209.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $171.0K |
| Free Cash FlowOCF − Capex | $2.4M | $-227.0K |
| FCF MarginFCF / Revenue | 12.7% | -0.9% |
| Capex IntensityCapex / Revenue | 3.4% | 1.6% |
| Cash ConversionOCF / Net Profit | 1.10× | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $171.0K | ||
| Q3 25 | $169.0K | $1.7M | ||
| Q2 25 | $3.9M | $4.2M | ||
| Q1 25 | $2.1M | $3.1M | ||
| Q4 24 | $3.2M | $2.2M | ||
| Q3 24 | $2.3M | $1.7M | ||
| Q2 24 | $4.5M | $4.6M | ||
| Q1 24 | $1.4M | $2.8M |
| Q4 25 | $2.4M | $-227.0K | ||
| Q3 25 | $-83.0K | $-177.0K | ||
| Q2 25 | $3.7M | $3.6M | ||
| Q1 25 | $1.9M | $2.6M | ||
| Q4 24 | $2.9M | $1.5M | ||
| Q3 24 | $2.3M | $-148.0K | ||
| Q2 24 | $4.5M | $4.2M | ||
| Q1 24 | $1.3M | $2.6M |
| Q4 25 | 12.7% | -0.9% | ||
| Q3 25 | -0.5% | -0.7% | ||
| Q2 25 | 21.4% | 13.1% | ||
| Q1 25 | 12.2% | 9.4% | ||
| Q4 24 | 18.0% | 6.0% | ||
| Q3 24 | 15.5% | -0.6% | ||
| Q2 24 | 30.1% | 16.1% | ||
| Q1 24 | 9.1% | 10.2% |
| Q4 25 | 3.4% | 1.6% | ||
| Q3 25 | 1.5% | 7.2% | ||
| Q2 25 | 0.8% | 2.4% | ||
| Q1 25 | 1.0% | 2.2% | ||
| Q4 24 | 1.4% | 3.0% | ||
| Q3 24 | 0.3% | 7.2% | ||
| Q2 24 | 0.1% | 1.6% | ||
| Q1 24 | 0.6% | 0.7% |
| Q4 25 | 1.10× | 0.08× | ||
| Q3 25 | 0.08× | 0.75× | ||
| Q2 25 | 1.75× | 5.79× | ||
| Q1 25 | 1.10× | 1.26× | ||
| Q4 24 | 1.60× | 1.14× | ||
| Q3 24 | 1.57× | 0.53× | ||
| Q2 24 | 2.46× | 5.54× | ||
| Q1 24 | 0.90× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
Segment breakdown not available.
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
